Mallinckrodt plc (NYSE: MNK) announced it closed the acquisition of the global portfolio of three commercial-stage topical hemostasis drugs from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE